A previous CB1 receptor blocker, Rimonabant, was approved in Europe in 2006 but was discontinued in 2008 owing to serious psychiatric side effects
Ken Berry
No prescription is required for b12 in Germany so that bit of standard fluff in the MHRA answer is irrelevant
The most common side effects were stomach issues like nausea, diarrhea, vomiting, reduced appetite, and constipation
In one clinical trial , 86% of participants without type 2 diabetes lost at least 5% of their body weight after 68 weeks but that also means nearly 14% of people lost less than that
CNS Drug Reviews 12:250275 Bowles D, Isayenkova J, Lim EK, Poppenberger B (2005) Glycosyltransferases: managers of small molecules